An Engineered HR1‐Stem Helix‐HR2 Trimeric Platform for Developing Broad‐Spectrum Coronavirus Vaccines
Advanced Science · 2026
DOI: 10.1002/advs.77384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xikui Sun und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Th…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Vaccines, Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Project of Guangzhou National Laboratory and State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Major Project of Guangzhou National Laboratory, National Natural Science Foundation of China.
Abstract (Originalsprache)
The rapid spread of immune‐evasive viral variants, exemplified by SARS‐CoV‐2, highlights the urgent need for broad‐spectrum coronavirus vaccines. Although multimeric display of the receptor‐binding domain (RBD) using exogenous scaffolds improve immune responses, such approaches may elicit off‐target immune responses against the scaffolds themselves and remain limited by rapid RBD antigenic drift. Here, we report the rational design of a self‐assembling trimeric subunit vaccine, termed RBD‐heptad repeat 1 (HR1)‐stem helix (SH)‐heptad repeat 2 (HR2) (RHS), which integrates the JN.1 RBD with a highly conserved SH epitope from SARS‐CoV‐2 within a native HR1‐HR2 trimeric scaffold via optimized linkers. RHS exhibits high structural stability, efficient trimerization, and enhanced antigen presentation. In mice, RHS elicits robust humoral and cellular immune responses, including potent cross‐ neutralizing antibodies against diverse SARS‐CoV‐2 variants and pan‐betacoronavirus SH‐specific antibodies. In K18‐hACE2 mice, RHS confers strong protection against both antigen‐matched and antigen‐mismatched Omicron variants, while intranasal immunization induces potent mucosal IgA and IgG responses. Furthermore, the modular RHS platform is readily adaptable to antigens from SARS‐CoV and MERS‐CoV, underscoring its versatility for pan‐coronavirus vaccine development. Together, these findings establish RHS as a generalizable strategy for overcoming viral immune evasion and advancing next‐generation vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
- Guangzhou National Laboratory, Guangzhou International Bio-Island, Guangzhou, China.
- Key Laboratory of Tropical Disease Control of Ministry of Education, Institute of Human Virology, Department of Pathogen Biology and Biosecurity, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- College of Life Sciences, Nankai University, Tianjin, China.
- Centre For Infection and Immunity Study (CIIS), School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China.
ORCID-Profile: Xikui Sun, Sidi Yang, Chunmei Li, Jingyou Yu, Deyin Guo
Förderung
- Joint Project of Guangzhou National Laboratory and State Key Laboratory of Respiratory Disease, Guangzhou Medical University
- Major Project of Guangzhou National Laboratory
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Project
Zitieren
APA
Sun, X., Fan, J., Xie, X., Shi, Y., Liu, X., Xu, T., Yang, S., Shi, K., Xie, C., Li, S., Chen, S., Cai, R., He, P., Ye, Y., Chen, T., Ma, X., Li, C., Yu, J., & Guo, D. (2026). An Engineered HR1‐Stem Helix‐HR2 Trimeric Platform for Developing Broad‐Spectrum Coronavirus Vaccines. Advanced Science. https://doi.org/10.1002/advs.77384
Vancouver
Sun X, Fan J, Xie X, Shi Y, Liu X, Xu T, et al. An Engineered HR1‐Stem Helix‐HR2 Trimeric Platform for Developing Broad‐Spectrum Coronavirus Vaccines. Advanced Science. 2026. doi:10.1002/advs.77384
BibTeX
@article{Sun2026,
author = {Sun, Xikui and Fan, Junhao and Xie, Xiaolu and Shi, Yuting and Liu, Xiaoqing and Xu, Tiefeng and Yang, Sidi and Shi, Keda and Xie, Chengshu and Li, Shixiong and Chen, Siwen and Cai, Ruoxi and He, Ping and Ye, Yuzhen and Chen, Tao and Ma, Xiancai and Li, Chunmei and Yu, Jingyou and Guo, Deyin},
title = {An Engineered HR1‐Stem Helix‐HR2 Trimeric Platform for Developing Broad‐Spectrum Coronavirus Vaccines},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77384}
}
EUVIMED